MKRN3 inhibits puberty onset via interaction with IGF2BP1 and regulation of hypothalamic plasticity.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
24 04 2023
Historique:
received: 03 08 2022
accepted: 24 02 2023
medline: 25 4 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: epublish

Résumé

Makorin ring finger protein 3 (MKRN3) was identified as an inhibitor of puberty initiation with the report of loss-of-function mutations in association with central precocious puberty. Consistent with this inhibitory role, a prepubertal decrease in Mkrn3 expression was observed in the mouse hypothalamus. Here, we investigated the mechanisms of action of MKRN3 in the central regulation of puberty onset. We showed that MKRN3 deletion in hypothalamic neurons derived from human induced pluripotent stem cells was associated with significant changes in expression of genes controlling hypothalamic development and plasticity. Mkrn3 deletion in a mouse model led to early puberty onset in female mice. We found that Mkrn3 deletion increased the number of dendritic spines in the arcuate nucleus but did not alter the morphology of GnRH neurons during postnatal development. In addition, we identified neurokinin B (NKB) as an Mkrn3 target. Using proteomics, we identified insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) as another target of MKRN3. Interactome analysis revealed that IGF2BP1 interacted with MKRN3, along with several members of the polyadenylate-binding protein family. Our data show that one of the mechanisms by which MKRN3 inhibits pubertal initiation is through regulation of prepubertal hypothalamic development and plasticity, as well as through effects on NKB and IGF2BP1.

Identifiants

pubmed: 37092553
pii: 164178
doi: 10.1172/jci.insight.164178
pmc: PMC10243807
doi:
pii:

Substances chimiques

Ribonucleoproteins 0
Gonadotropin-Releasing Hormone 33515-09-2
MKRN3 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Mkrn3 protein, mouse EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : R37 HD019938
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD098684
Pays : United States
Organisme : NIA NIH HHS
ID : U54 AG062322
Pays : United States
Organisme : Wellcome Trust
ID : 211221/Z/18/Z
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD082314
Pays : United States
Organisme : NICHD NIH HHS
ID : R00 HD091381
Pays : United States

Références

Endocrinology. 2015 Jun;156(6):2313-22
pubmed: 25856429
N Engl J Med. 2013 Jun 27;368(26):2467-75
pubmed: 23738509
Lancet Diabetes Endocrinol. 2016 Mar;4(3):254-264
pubmed: 26852256
J Proteome Res. 2018 Jun 1;17(6):2226-2236
pubmed: 29734811
Front Endocrinol (Lausanne). 2019 Feb 08;10:48
pubmed: 30800097
Endocrinology. 2022 Oct 11;163(11):
pubmed: 35974456
J Neurosci. 2011 Apr 6;31(14):5271-85
pubmed: 21471362
Nat Rev Endocrinol. 2016 Aug;12(8):452-66
pubmed: 27199290
J Neuroendocrinol. 2021 Sep;33(9):e13020
pubmed: 34423876
Cell Mol Life Sci. 2013 Aug;70(15):2657-75
pubmed: 23069990
J Clin Endocrinol Metab. 2001 Jun;86(6):2364-8
pubmed: 11397824
Mol Cell Neurosci. 2012 Mar;49(3):351-63
pubmed: 22182708
N Engl J Med. 2003 Oct 23;349(17):1614-27
pubmed: 14573733
Curr Protoc Neurosci. 2017 Oct 24;81:3.33.1-3.33.24
pubmed: 29064566
J Neurosci. 2009 Sep 23;29(38):11859-66
pubmed: 19776272
Nat Struct Mol Biol. 2011 May;18(5):520-8
pubmed: 21540891
Nature. 2014 Oct 02;514(7520):92-97
pubmed: 25231870
Endocrinology. 2006 Dec;147(12):5817-25
pubmed: 16959837
Development. 2015 Feb 15;142(4):633-43
pubmed: 25670790
Endocrinology. 2012 Oct;153(10):4883-93
pubmed: 22893725
J Neurosci. 2012 Feb 15;32(7):2388-97
pubmed: 22396413
Endocrinology. 2006 Aug;147(8):3652-61
pubmed: 16644918
Hum Mol Genet. 1999 May;8(5):783-93
pubmed: 10196367
Cell. 2009 Jul 23;138(2):389-403
pubmed: 19615732
Hum Mol Genet. 2015 Dec 20;24(25):7326-38
pubmed: 26464488
J Clin Endocrinol Metab. 2021 Mar 25;106(4):1041-1050
pubmed: 33383582
Hum Mol Genet. 1999 May;8(5):795-803
pubmed: 10196368
Endocrinology. 2021 Jan 1;162(1):
pubmed: 33175140
J Clin Invest. 2020 Aug 3;130(8):4486-4500
pubmed: 32407292
Nat Genet. 2009 Mar;41(3):354-358
pubmed: 19079066
Neuroendocrinology. 1986;43(2):93-7
pubmed: 3523280
J Endocr Soc. 2019 Mar 25;3(5):979-995
pubmed: 31041429
Reproduction. 2005 Aug;130(2):203-12
pubmed: 16049158
PLoS Biol. 2019 Nov 7;17(11):e3000532
pubmed: 31697675
Mol Cell Biol. 2004 May;24(10):4448-64
pubmed: 15121863
Natl Sci Rev. 2020 Mar;7(3):671-685
pubmed: 34692086
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Nat Genet. 2017 Jun;49(6):834-841
pubmed: 28436984
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
PLoS One. 2014 Sep 10;9(9):e107591
pubmed: 25208214
J Mol Endocrinol. 2015 Jun;54(3):R131-9
pubmed: 25957321
Nucleic Acids Res. 2005 Dec 14;33(22):7074-89
pubmed: 16356927
Development. 2012 Sep;139(18):3326-31
pubmed: 22912413
Cell Rep. 2016 Apr 19;15(3):666-679
pubmed: 27068461
Nat Neurosci. 2010 Jun;13(6):767-75
pubmed: 20436479
Curr Opin Endocr Metab Res. 2020 Oct;14:152-159
pubmed: 32984644
Semin Reprod Med. 2019 Jul;37(4):166-173
pubmed: 31972861
Endocrinology. 2019 Oct 1;160(10):2453-2463
pubmed: 31504389
Front Cell Neurosci. 2015 May 27;9:204
pubmed: 26074772
J Exp Med. 2021 Aug 2;218(8):
pubmed: 34143182
Nature. 2020 Jun;582(7811):246-252
pubmed: 32499648
Nucleic Acids Res. 2021 Apr 19;49(7):3796-3813
pubmed: 33744966
J Clin Endocrinol Metab. 2010 May;95(5):2287-95
pubmed: 20194706
J Clin Endocrinol Metab. 2010 Jun;95(6):2857-67
pubmed: 20332248
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10972-6
pubmed: 12944565
J Clin Invest. 2015 Feb;125(2):796-808
pubmed: 25555215
J Endocrinol. 2014 Feb 10;220(3):375-88
pubmed: 24403293
Oncotarget. 2017 Jul 18;8(49):85102-85109
pubmed: 29156706
Neuron. 2001 Aug 2;31(2):261-75
pubmed: 11502257
Front Neuroendocrinol. 2017 Jan;44:122-137
pubmed: 28007528

Auteurs

Lydie Naulé (L)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Alessandra Mancini (A)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Sidney A Pereira (SA)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Brandon M Gassaway (BM)

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.

John R Lydeard (JR)

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.

John C Magnotto (JC)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Han Kyeol Kim (HK)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Joy Liang (J)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Cynara Matos (C)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Steven P Gygi (SP)

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.

Florian T Merkle (FT)

Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust - Medical Research Council Institute of Metabolic Science and.
Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Rona S Carroll (RS)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Ana Paula Abreu (AP)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Ursula B Kaiser (UB)

Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH